Pli­ant Ther­a­peu­tics re­leas­es longer-term safe­ty, pre­lim­i­nary ef­fi­ca­cy da­ta from PhI­Ia study

A new up­date on Pli­ant Ther­a­peu­tics’ oral drug for id­io­path­ic pul­monary fi­bro­sis (IPF) sug­gests its safe­ty and ear­ly signs of ef­fi­ca­cy are hold­ing up in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER